A pilot study evaluating the impact of Taxotere, Cisplatin and 5-Fluorouracil (TPF) induction chemotherapy on intratumoral hypoxia in locoregionally advanced head and neck squamous cell cancer.
Phase of Trial: Phase III
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Pharmacodynamics
- 08 Jun 2016 Status changed from recruiting to completed.
- 10 Aug 2009 New trial record